Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 820027 MINNEAPOLIS, MN
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
271,938
-63.9% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $3,403,585,552 across 30 Diagnostics & Research names. ADPT ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 1,547,342 $775,775,381
2 GH
Guardant Health, Inc.
 3,150,897 $472,729,076
3 DHR
Danaher Corp /De/
 2,331,466 $444,097,640
4 ILMN
Illumina, Inc.
 1,148,102 $201,870,770
5 CRL
Charles River Laboratories International, Inc.
 881,189 $199,844,850
6 ICLR
Icon PLC
 979,596 $170,165,619
7 WAT
Waters Corp /De/
 436,388 $163,662,953
8 DGX
Quest Diagnostics Inc
 759,975 $161,076,698

All Filings in ADPT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 — 1,087,754
2026-03-31 — 3,017,341
2025-12-31 — 2,590,984
2025-09-30 — 5,971,706
2025-06-30 — 3,240,058
2025-03-31 — 6,642,476
2024-12-31 — 736,720
2024-09-30 — 82,411
2024-06-30 — 50,909
2024-03-31 — 846,379
2023-12-31 — 54,934
2023-09-30 — 79,619
2023-06-30 — 52,457
2023-03-31 — 427,964
2022-12-31 — 368,900
2022-03-31 — 648,479
2021-12-31 — 580,274
2021-09-30 — 580,500
2021-06-30 — 533,082
2021-03-31 — 853,032
2020-12-31 — 755,542
2020-09-30 — 591,408
2020-06-30 — 345,116
2020-03-31 — 332,671